drugset / Trial / NCT00382616
Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine whether supplementation of omega-3 long-chain polyunsaturated fatty acid conjugated to phosphatidylserine rather than triglycerides (fish oil) could affect Attention-deficit/hyperactivity disorder symptoms in children.
Timeline
- Start
- 2004-07
- Primary completion
- —
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phosphatidylserine-Omega3 | Other / unclassified | 300 mg | — |